Catalyst Wire Dossier Catalyst Wire Dossier

Taldefgrobep alfa

taldefgrobep alfa · Biohaven Therapeutics Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Taldefgrobep alfa, covering 2026-02-04 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Taldefgrobep Alfa in Adults With Overweight and Obesity [Phase 2]

See pricing